Meningioma secondary prevention

Jump to navigation Jump to search

Meningioma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Meningioma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Meningioma secondary prevention On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Meningioma secondary prevention

All Images
X-rays
Echo and Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Meningioma secondary prevention

CDC on Meningioma secondary prevention

Meningioma secondary prevention in the news

Blogs on Meningioma secondary prevention

Directions to Hospitals Treating Meningioma

Risk calculators and risk factors for Meningioma secondary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

The reasons of developing meningioma are not clear. Epidemiological survey demonstrates the folling measure may be helpful:

  • Avoidance over-dosage radiation therapy on head.
  • Early screening of disorder neurofibromatosis type 2.

References


Template:WikiDoc Sources